NeuroOne Medical Technologies
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. NeuroOne Medical Technologies's past years’ income statements indicate that its last revenue has increased compared to the previous period by 77% to $3,453,003. Profit margin reached -357%. Total operating expenses were $12,966,876.

Profit Margin

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC): Profit margin
2015 742 -62.86K -8472.1%
2016 0 -47.77K
2017 0 -5.05M
2018 0 0
2019 0 -6.78M
2020 1.92M -13.64M -708%
2021 178.14K -9.94M -5584.28%
2022 171.16K -9.99M -5841.95%
2023 1.95M -11.85M -607.42%
2024 3.45M -12.31M -356.74%

NMTC Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
3.45M1.95M171.16K178.14K1.92M0000742
Cost of revenue
2.37M1.49M241.96K275.89K1.86M27.56K017.63K00
Gross profit
1.07M456.51K-70.79K-97.74K63.11K-27.56K0-17.63K0742
Operating exp.
Research and development
5.06M6.94M4.92M3.92M2.07M1.52M0735.33K02.4K
Selling and marketing
0173.43K270.61K338.83K0000022.97K
Total operating expenses
12.96M12.41M9.95M10.12M4.90M5.81M03.07M32.61K30.91K
Operating income
-11.88M-11.95M-10.03M-10.21M-4.90M-5.81M0-3.07M-32.61K-30.91K
Other income (expenses), net
-430.90K95.75K31.15K273.09K-8.73M-683.21K0-1.98M00
Income before tax
-12.31M-11.85M-9.99M-9.94M-13.64M-6.78M0-5.05M-32.61K-30.91K
Income tax expense
000274.17K7.52M284.55K01.39M15.16K31.94K
Net income
-12.31M-11.85M-9.99M-9.94M-13.64M-6.78M0-5.05M-47.77K-62.86K
Earnings per share
Basic EPS
-0.46-0.65-0.63-0.93-2.52-1.720-2.3-0.02-0.03
Diluted EPS
-0.46-0.65-0.63-0.93-2.52-1.720-2.3-0.02-0.03
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source